MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Comparing Portal Vein Assessment by Intraoperative Doppler and Transesophageal Echocardiography

Not yet recruiting
Conditions
Chronic Liver Disease
First Posted Date
2025-04-03
Last Posted Date
2025-04-03
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
25
Registration Number
NCT06909175

The Study of Association of Helicobacter Infections in Biliary Tract Cancers

Not yet recruiting
Conditions
Biliary Tract Cancer
First Posted Date
2025-04-03
Last Posted Date
2025-04-03
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
250
Registration Number
NCT06909188
Locations
🇮🇳

ILBS, New Delhi, Delhi, India

Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.

Not Applicable
Not yet recruiting
Conditions
Autoimmune Hepatitis
Interventions
Biological: Plasma Exchange
Dietary Supplement: Diet
Drug: Steroid
First Posted Date
2025-03-04
Last Posted Date
2025-03-04
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
50
Registration Number
NCT06855667
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices

Not Applicable
Not yet recruiting
Conditions
Hepatocellular Carcinoma
Interventions
Drug: Carvedilol Tablets
Procedure: Endoscopic Variceal Ligation
First Posted Date
2025-02-20
Last Posted Date
2025-02-20
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
100
Registration Number
NCT06836778
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy

Not Applicable
Not yet recruiting
Conditions
Acute-On-Chronic Liver Failure
First Posted Date
2025-02-18
Last Posted Date
2025-02-18
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
934
Registration Number
NCT06831565
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure

Not Applicable
Not yet recruiting
Conditions
Acute Liver Failure
Interventions
Drug: Standard Medical treatment
Biological: Therapeutic Plasma Excahnge
First Posted Date
2025-02-18
Last Posted Date
2025-02-18
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
40
Registration Number
NCT06831643
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis

Phase 2
Not yet recruiting
Conditions
Portal Vein Thrombosis
Liver Cirrhosis
Interventions
First Posted Date
2025-02-10
Last Posted Date
2025-02-10
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
120
Registration Number
NCT06818279
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

Not Applicable
Not yet recruiting
Conditions
Acute-On-Chronic Liver Failure
Interventions
First Posted Date
2025-02-10
Last Posted Date
2025-02-10
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
150
Registration Number
NCT06818565
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal Bleed

Phase 2
Not yet recruiting
Conditions
Acute on Chronic Liver Failure
Interventions
First Posted Date
2025-02-07
Last Posted Date
2025-02-07
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
60
Registration Number
NCT06815770
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury

Not Applicable
Not yet recruiting
Conditions
Liver Cirrhosis
Acute Kidney Injury
Interventions
Other: Standard Medical Treatment
First Posted Date
2025-02-05
Last Posted Date
2025-02-05
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
100
Registration Number
NCT06809088
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath